stockCELYAD ONCOLOGY Stock Went Down By Over 29% In The Last 21 SessionsViaNews Editorial Team (Europe)•Mar 21, 2023
stockFINATIS And NYRSTAR On The List Of Winners And Losers Of Monday's Euronext SessionViaNews Editorial Team (Europe)•Mar 20, 2023
stockCELYAD ONCOLOGY Stock Bullish Momentum With A 10% Jump At Session Start TodayViaNews Editorial Team (Europe)•Mar 20, 2023
stockCELYAD ONCOLOGY Stock Bearish Momentum With A 11% Fall At Session Start TodayViaNews Editorial Team (Europe)•Mar 16, 2023
stockCELYAD ONCOLOGY Stock Bearish Momentum With A 27% Drop In The Last 21 SessionsViaNews Editorial Team (Europe)•Mar 14, 2023
stockCELYAD ONCOLOGY Stock Falls By 20% In The Last 10 SessionsViaNews Editorial Team (Europe)•Mar 6, 2023
stockCELYAD ONCOLOGY Stock Over 34% Down In The Last 21 SessionsViaNews Editorial Team (Europe)•Feb 22, 2023